advanced search
Venkata Appa Reddy Goli
Research Fellow, Formulation and Process Development
ten23 health

Is this your profile?

About

Venkata Appa Reddy Goli is a Research Fellow, Formulation and Process Development, at ten23 health. He worked previously as a senior scientist at Thermo Fisher Scientific from 2021 to 2023, Biocon Biologics from 2019 to 2021 and Pfizer’s biologics development centre from 2014 to 2019. He has a pharmaceutical background and holds a master’s degree in Pharmaceutics from NIPER, Mohali (India). He has extensive knowledge of formulation development, container closure selection, lyophilisation and process development and characterisation. Throughout his career, Mr Goli has played a key role in platform formulation and process development.

Contributions

INJECTION
TRANSITIONING FROM VIAL TO SUBCUTANEOUS INJECTION DEVICES FOR BIOLOGICAL DRUG PRODUCTS
Michael Adler, Venkata Appa Reddy Goli, Andrea Allmendinger and Hanns-Christian Mahler, discuss the various factors that need to be considered when transferring to a delivery device for subcutaneous injection, such as a prefilled syringe or autoinjector, during clinical trials or post-launch, especially when transferring from a vial format for intravenous infusion.
Top